Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
HilleVax logo — HilleVax is a biopharmaceutical company focused on the devel...

HilleVax

HilleVax is a biopharmaceutical company focused on the development and commercialization of novel vaccines.

Founded 2021 United States Boston, United States 76 employees Post Ipo Equity Total: $235.00M Biopharma, Biotechnology +2

General Information

Company Name HilleVax
Founded Year 2021
Location United States Boston, United States +1
Employees 76
Industries Biopharma, Biotechnology, Health Care +1
Funding Stage Post Ipo Equity
Social

Get notified when HilleVax moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About HilleVax

HilleVax is a biopharmaceutical company founded in 2021 with a focus on the development and commercialization of novel vaccines. The company's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate aimed at preventing moderate-to-severe acute gastroenteritis caused by norovirus infection. HilleVax, based in the United States, recently secured a significant $100.00M Post-IPO Equity investment on 19 September 2023. This infusion of capital reflects a robust interest in the company's innovative approach to vaccine development and marks a significant milestone in its growth trajectory. The continued support from investors underscores the potential of HilleVax in shaping the future of biopharma, biotechnology, health care, and the pharmaceutical industry.

Taxonomy: Biopharmaceutical, Vaccine development, Novel vaccines, Virus-like particle (VLP) vaccine, Gastroenteritis prevention, Norovirus, Biotech startup, Healthcare innovation, Biopharmaceutical industry, Clinical development, Commercialization, Medical research, Bioengineering, Bioinnovation, Health technology

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Post-IPO Equity •••••• - 19 Sep 2023
Venture Round •••••• 10
Investor Investor Investor Investor Investor Investor Investor
•••• •••• 		08 Sep 2021

HilleVax Alternatives & Competitors

HilleVax vs
辽宁依生生物制药有限公司
辽宁依生生物制药有限公司

Pioneering groundbreaking biotherapeutics for cancers and infectious diseases with innovative PIKA®...

Post Ipo Equity
26 employees
Biopharma, Biotechnology
Compare HilleVax vs 辽宁依生生物制药有限公司
HilleVax vs
Pegasus Biotech Inc.
Pegasus Biotech Inc. Canada

Getting you to market faster!

Grant
10 employees
Biopharma, Biotechnology
Compare HilleVax vs Pegasus Biotech Inc.
HilleVax vs
IO Biotech
IO Biotech Denmark

Break Boundaries. Ignite Change.

Post Ipo Equity
91 employees
Biotechnology, Health Care
Compare HilleVax vs IO Biotech

FAQ About HilleVax

HilleVax is a biopharmaceutical company focused on the development and commercialization of novel vaccines.
HilleVax was founded in 2021.
HilleVax is headquartered in Boston, United States.
HilleVax operates in the following industries: Biopharma, Biotechnology, Health Care, Pharmaceutical.
HilleVax has approximately 76 employees.
HilleVax has completed 2 funding rounds, raising a total of $235.00M. The latest funding stage is Post Ipo Equity.
Top alternatives and competitors to HilleVax include 辽宁依生生物制药有限公司, Pegasus Biotech Inc., IO Biotech, VBI Vaccines Inc., Intravacc. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
HilleVax and 辽宁依生生物制药有限公司 are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors HilleVax and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy